XENE – xenon pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
Xenon Pharmaceuticals (NASDAQ:XENE) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
Xenon Pharmaceuticals (NASDAQ:XENE) had its price target raised by analysts at JPMorgan Chase & Co. from $60.00 to $62.00. They now have an "overweight" rating on the stock.
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference [Canadian Business Journal (Canada)]
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Form 4 Xenon Pharmaceuticals For: Jan 09 Filed by: KENNEY CHRISTOPHER JOHN
Form 4 Xenon Pharmaceuticals For: Jan 09 Filed by: Cline Darren S
Form 4 Xenon Pharmaceuticals For: Jan 09 Filed by: DiFabio Andrea
Form 4 Xenon Pharmaceuticals For: Jan 09 Filed by: MORTIMER IAN
Form 4 Xenon Pharmaceuticals For: Jan 02 Filed by: MORTIMER IAN
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.